Proxim Diagnostics receives strategic investment from bioMérieux
Santa Clara, California-based Proxim Diagnostics, a company developing a handheld, point-of care diagnostic device, has received a strategic investment from bioMérieux, a world leader in the field of in vitro diagnostics.
